Posted Nov. 12, 2013 at 6:44 a.m.

Premium Lock GSK drug candidate fails to lower heart attack risk in study

Published: 2013-11-12 06:44:00
Updated: 2013-11-12 06:44:00

Heart research Heart research Image 1 of 2 · Next Image…

GlaxoSmithKline's experimental drug darapladib didn't reduce the risk of heart attack or stroke in a late-stage study, the second time the medicine disappointed in clinical trials....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2014 Bloomberg. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Frank Vinluan
Life science
Vivek Wadhwa
Commentary
Dr. Mike Walden
Tech economy
Scroll